Health Education Approach to Lung Screening

Part of paid clinical trials in Carrboro, North Carolina.

Sponsor
Virginia Commonwealth University
Study ID
NCT06070870
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - 80 Years
Healthy Volunteers
Accepted

Interventions

  • Patient Navigation — BEHAVIORAL
    Navigation will address the following 4 domains of barriers to screening: * Individual * Organizational * Economic * Sociocultural At the first visit, navigators will assess the participant's barriers in each of these domains. Any follow-up visits, if necessary, will be used to help the participant overcome these barriers to screening

Study Details

Evaluate the impact of the patient navigation program on the proportion of patients who complete lung cancer screening (LCS), defined as undergoing a low dose computed tomography (LDCT)

Key Dates

Start date
Oct 10, 2023
Status verified
May 2026
Primary completion
Nov 30, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
675 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING

Arms

  • Experimental: Patient Navigation
    Centralized patient navigators will be trained to help patients navigate the clinical, logistical, and financial aspects of LCS. Navigators employ case management approaches based on social work principles. The experience of patient navigation will be tailored to the individual participant

Primary Outcome Measure

Number of study patients who complete lung cancer screening (LCS) through the patient navigation process [ Time Frame: 2 weeks to 10 months following day 1, varies by participant ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
University of North Carolina-Chapel HillCarrboroNorth Carolina27510
Christopher Lyu, MPA
[email protected]
(919) 966-2865
Alison Brenner, MD
(919) 966-2865
Alison Brenner, MD (PRINCIPAL_INVESTIGATOR)
Medical University of South CarolinaCharlestonSouth Carolina29425
Megan Ellison, Ed.D
[email protected]
843-876-2428
Marvella Ford, MD
843-876-2428
Marvella Ford, MD (PRINCIPAL_INVESTIGATOR)
Virginia Commonwealth UniversityRichmondVirginia23298
Massey CPC Team
[email protected]
804-628-6430
Vanessa Sheppard, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Carrboro, NC

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
University of North Carolina-Chapel Hill· Carrboro, NCMedical University of South Carolina· Charleston, SCVirginia Commonwealth University· Richmond, VA

Related Studies